Cargando…

Antiphospholipid Antibodies to Domain I of Beta-2-Glycoprotein I Show Different Subclass Predominance in Comparison to Antibodies to Whole Beta-2-glycoprotein I

Antiphospholipid antibodies (aPL), the serological hallmark of antiphospholipid syndrome (APS), are a heterogeneous group of autoantibodies raised against circulating blood proteins. Of these proteins, the phospholipid-binding b2-glycoprotein I (β2GPI) is considered to be the main autoantigen in APS...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDonnell, Thomas, Artim-Esen, Bahar, Wincup, Chris, Ripoll, Vera M., Isenberg, David, Giles, Ian P., Rahman, Anisur, Pericleous, Charis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173128/ https://www.ncbi.nlm.nih.gov/pubmed/30323817 http://dx.doi.org/10.3389/fimmu.2018.02244

Ejemplares similares

Antibodies to domain I of β-2-glycoprotein I and IgA antiphospholipid antibodies in patients with ‘seronegative’ antiphospholipid syndrome
por: Cousins, Laura, et al.
Publicado: (2015)

The role of beta-2-glycoprotein I in health and disease associating structure with function: More than just APS
por: McDonnell, Thomas, et al.
Publicado: (2020)

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome
por: Willis, Rohan, et al.
Publicado: (2022)

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits the Binding, Coagulopathic, and Thrombogenic Properties of IgG From Patients With the Antiphospholipid Syndrome
por: McDonnell, Thomas C. R., et al.
Publicado: (2018)

Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays
por: Artim-Esen, Bahar, et al.
Publicado: (2015)

Domain I of β2GPI is capable of blocking serum IgA antiphospholipid antibodies binding in vitro: an effect enhanced by PEGylation
por: Albay, A, et al.
Publicado: (2019)

Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome
por: Raimondo, Maria Gabriella, et al.
Publicado: (2017)

Development of a high yield expression and purification system for Domain I of Beta-2-glycoprotein I for the treatment of APS
por: McDonnell, Thomas, et al.
Publicado: (2015)

The Significance of Anti-Beta-2-Glycoprotein I Antibodies in Antiphospholipid Syndrome
por: Brusch, Anna
Publicado: (2016)

Measuring IgA Anti-β2-Glycoprotein I and IgG/IgA Anti-Domain I Antibodies Adds Value to Current Serological Assays for the Antiphospholipid Syndrome
por: Pericleous, Charis, et al.
Publicado: (2016)

Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies
por: Pericleous, Charis, et al.
Publicado: (2011)

Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?
por: Pericleous, Charis, et al.
Publicado: (2020)

Antibodies to beta(2)-glycoprotein I, prothrombin and antithrombin III as markers of the antiphospholipid syndrome severity
por: Zabek, J, et al.
Publicado: (2001)

Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and/or Antiphospholipid Syndrome
por: Artim-Esen, Bahar, et al.
Publicado: (2017)

A novel expression system of domain I of human beta2 glycoprotein I in Escherichia coli
por: Ioannou, Yiannis, et al.
Publicado: (2006)

Specific domain V reduction of beta-2-glycoprotein I induces protein flexibility and alters pathogenic antibody binding
por: Buchholz, Ina, et al.
Publicado: (2021)

Posttranslational forms of beta 2-glycoprotein I in the pathogenesis of the antiphospholipid syndrome
por: El-Assaad, Fatima, et al.
Publicado: (2016)

Antiphospholipid antibody positivity in early systemic lupus erythematosus is associated with subsequent vascular events
por: Farina, Nicola, et al.
Publicado: (2022)

Antibodies to FXa and thrombin in patients with SLE differentially regulate C3 and C5 cleavage
por: McDonnell, Thomas, et al.
Publicado: (2022)

Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β(2)-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis
por: Pericleous, Charis, et al.
Publicado: (2015)

Anticardiolipin and anti-beta2-glycoprotein I antibodies in Behcet's disease.
por: Kang, H. J., et al.
Publicado: (1998)

Methodology of generation and purification of anti-beta 2 glycoprotein I antibodies
por: Alarcon, Marcelo, et al.
Publicado: (2019)

Anticardiolipin and anti‐beta 2‐glycoprotein I antibodies in patients with unexplained articular manifestations
por: Melayah, Sarra, et al.
Publicado: (2022)

Antiphospholipid antibodies enhance rat neonatal cardiomyocyte apoptosis in an in vitro hypoxia/reoxygenation injury model via p38 MAPK
por: Bourke, Lauren T, et al.
Publicado: (2017)

Autoantibodies Directed Against Domain I of Beta2-Glycoprotein I
por: de Laat, Bas, et al.
Publicado: (2010)

Anticardiolipin and anti-beta-2 glycoprotein I antibodies in patients with moderate or severe COVID-19
por: Garcia-Arellano, Gisela, et al.
Publicado: (2023)

Heterogeneous behaviour of anti-beta(2)-glycoprotein I antibodies on different "high binding" microtiter plates
por: Ambrozic, A, et al.
Publicado: (2001)

Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation
por: Serrano, Manuel, et al.
Publicado: (2019)

Novel Assays of Thrombogenic Pathogenicity in the Antiphospholipid Syndrome Based on the Detection of Molecular Oxidative Modification of the Major Autoantigen β(2)-Glycoprotein I
por: Ioannou, Yiannis, et al.
Publicado: (2011)

Influence of anticardiolipin and anti‐β2 glycoprotein I antibody cutoff values on antiphospholipid syndrome classification
por: Vanoverschelde, Laura, et al.
Publicado: (2019)

IgA is the predominant isotype of anti‐β2 glycoprotein I antibodies in rheumatoid arthritis
por: Melayah, Sarra, et al.
Publicado: (2020)

Interactions of human monoclonal and polyclonal antiphospholipid antibodies with serine proteases involved in hemostasis
por: Lambrianides, Anastasia, et al.
Publicado: (2011)

Gene expression profiling identifies distinct molecular signatures in thrombotic and obstetric antiphospholipid syndrome
por: Ripoll, Vera M., et al.
Publicado: (2018)

Evaluation of the diagnostic potential of antibodies to beta2-glycoprotein 1 domain 1 in Chinese patients with antiphospholipid syndrome
por: Zhang, Shulan, et al.
Publicado: (2016)

Effects of anti‐beta 2‐glycoprotein 1 antibodies and its association with pregnancy‐related morbidity in antiphospholipid syndrome
por: Fierro, Juan J., et al.
Publicado: (2021)

Beta‐2‐Glycoprotein‐I Deficiency Could Precipitate an Antiphospholipid Syndrome‐like Prothrombotic Situation in Patients With Coronavirus Disease 2019
por: Serrano, Manuel, et al.
Publicado: (2021)

Isolated IgA Anti-β2 Glycoprotein I Antibodies in Patients with Clinical Criteria for Antiphospholipid Syndrome
por: Ruiz-García, Raquel, et al.
Publicado: (2014)

Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface
Publicado: (1994)

Optimization of Unnicked β2-Glycoprotein I and High Avidity Anti-β2-Glycoprotein I Antibodies Isolation
por: Artenjak, Andrej, et al.
Publicado: (2014)

New insight into antiphospholipid syndrome: antibodies to β2glycoprotein I-domain 5 fail to induce thrombi in rats
por: Durigutto, Paolo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_b7e8nu6e50ec4riid25qlp6fn3